A detailed history of Leelyn Smith, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Leelyn Smith, LLC holds 43,507 shares of BMY stock, worth $2.31 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
43,507
Previous 38,525 12.93%
Holding current value
$2.31 Million
Previous $2.09 Million 13.55%
% of portfolio
0.35%
Previous 0.42%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$40.25 - $52.99 $200,525 - $263,996
4,982 Added 12.93%
43,507 $1.81 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $80,654 - $91,446
1,681 Added 4.56%
38,525 $2.09 Million
Q4 2023

Feb 08, 2024

BUY
$48.48 - $57.85 $29,330 - $34,999
605 Added 1.67%
36,844 $1.89 Million
Q3 2023

Nov 06, 2023

BUY
$57.89 - $64.73 $37,686 - $42,139
651 Added 1.83%
36,239 $2.1 Million
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $92,188 - $102,360
-1,447 Reduced 3.91%
35,588 $2.28 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $36,337 - $41,215
553 Added 1.52%
37,035 $2.57 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $146,684 - $173,694
2,142 Added 6.24%
36,482 $2.62 Million
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $81,116 - $89,337
1,117 Added 3.36%
34,340 $2.64 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $59,820 - $71,729
973 Added 3.02%
33,223 $2.43 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $22,792 - $26,571
-425 Reduced 1.3%
32,250 $2.01 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $473 - $554
8 Added 0.02%
32,675 $1.93 Million
Q2 2021

Aug 31, 2021

BUY
$61.91 - $67.42 $31,574 - $34,384
510 Added 1.59%
32,667 $2.18 Million
Q1 2021

May 05, 2021

BUY
$59.34 - $66.74 $52,100 - $58,597
878 Added 2.81%
32,157 $2.03 Million
Q4 2020

Jan 15, 2021

SELL
$57.74 - $65.43 $25,925 - $29,378
-449 Reduced 1.42%
31,279 $1.94 Million
Q3 2020

Nov 05, 2020

BUY
$57.43 - $63.64 $1.77 Million - $1.96 Million
30,808 Added 3348.7%
31,728 $1.91 Million
Q2 2020

Aug 06, 2020

SELL
$54.82 - $64.09 $1.77 Million - $2.06 Million
-32,218 Reduced 97.22%
920 $1.9 Million
Q1 2020

May 06, 2020

BUY
$46.4 - $67.43 $99,806 - $145,041
2,151 Added 6.94%
33,138 $1.85 Million
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $1.52 Million - $1.99 Million
30,987 New
30,987 $1.99 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Leelyn Smith, LLC Portfolio

Follow Leelyn Smith, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leelyn Smith, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leelyn Smith, LLC with notifications on news.